Literature DB >> 7387055

Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse.

N Bosseray, M Plommet.   

Abstract

Three fractions extracted from Brucella possessing immunogenic activity were tested either as unique antigens or in combinations using various dose levels. Immunity in the mouse was tested one month after vaccination by the intraperitoneal administration of a virulent strain of B. abortus and the spleen count of Brucella 15 days after challenge. The brucellin protein fraction, the cutaneous hypersensitivity reagent did not immunize the mouse and did not interfere with the immunization produced by the PG (cell wall PG extracted with SDS) and LPS fractions. The PG fractions, extracted either from B. abortus (PG-F8) or from B. melitensis (PG-F7), conferred good dose-dependent immunity used on their own. The LPS fraction (B. melitensis) on its own also conferred good immunity but the dose-response curve was less regular. Immunity induced by either fraction was not affected by the presence of an oil adjuvant. Various dose-ratio combinations of PG and LPS were studied with respect to their interactions in three successive factorial experiments. The interactions were consistently significant and largely negative. According to the dose of each fraction and the ratio, the immunity was either equivalent to that produced by the most active fraction in the combination (no additive effect) or less (antagonism). The antagonism between two vaccinal fractions extracted from the same bacteria pleads in favour of purified vaccines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387055

Source DB:  PubMed          Journal:  Ann Microbiol (Paris)        ISSN: 0300-5410


  4 in total

1.  Analysis of Brucella lipopolysaccharide with specific and cross-reacting monoclonal antibodies.

Authors:  D A Palmer; J T Douglas
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

2.  Vaccine and serum-mediated protection against brucella infection of mouse placenta.

Authors:  N Bosseray
Journal:  Br J Exp Pathol       Date:  1983-12

3.  Generation of chemotactic factor for granulocytes and monocytes from serum by fractions of Brucella abortus.

Authors:  J R Birmingham; L B Tabatabai; B L Deyoe; E L Jeska; M E Nuessen
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

4.  Immune serum-mediated effects on brucellosis evolution in mice.

Authors:  M Plommet; A M Plommet
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.